About: Christine Lacabaratz

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Christine Lacabaratz Goto Sponge NotDistinct Permalink

An Entity of Type : foaf:Person, within Data Space : data.idref.fr associated with source document(s)

Attributes	Values
type	Person
Life Event	http://www.idref.fr/278871208/birth
preferred label	Lacabaratz, Christine (19..-….)
name	Christine Lacabaratz
Given name	Christine
familyName	Lacabaratz
has biographical i...tion (Deprecated)	Vaccine Research Institute (VRI), Créteil F-94000, France; Inserm U955, Henri Mondor Hospital, University of Paris East, F-94000 Créteil, France.
gender	female
is sameAs of	Lacabaratz, Christine (19..-….) Lacabaratz, Christine (19..-….)
is Author of	Anti-HIV potency of T-cell responses elicited by dendritic cell therapeutic vaccination Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques Gene Expression Signatures Associated With Immune and Virological Responses to Therapeutic Vaccination With Dendritic Cells in HIV-Infected Individuals Vaccination with dendritic cells loaded with HIV-1 lipopeptides elicits broad T cell immunity and control of viral load in HIV infected patients Long-lasting severe immune dysfunction in Ebola virus disease survivors A randomized placebo-controlled efficacy study of a prime boost therapeutic vaccination strategy in HIV-1 infected individuals: VRI02 ANRS 149 LIGHT Phase II trial Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome HIV Controllers Have Low Inflammation Associated with a Strong HIV-Specific Immune Response in Blood Targeting human langerin promotes HIV-1 specific humoral immune responses Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. HIV infection en route to endogenization: two cases Optimization and evaluation of Luminex performance with supernatants of antigen-stimulated peripheral blood mononuclear cells Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells. A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial Analyzing cellular immunogenicity in vaccine clinical trials: a new statistical method including non-specific responses for accurate estimation of vaccine effect Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study. Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial
is primary topic of	http://www.idref.fr/278871208

Faceted Search & Find service v1.13.91 as of Aug 16 2018

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software